NCT03372928

Brief Summary

The amount of essential amino acids (EAA) necessary to maximally stimulate muscle protein synthesis and optimize whole-body net protein balance during caloric deprivation has not been determined. This study will address that gap in knowledge by examining the resting and post-exercise muscle and whole-body protein kinetic responses to ingesting varying amounts of EAA after a 5 day period of negative energy balance. This study will provide the initial evidence to support the development of a recovery-based food product for military combat rations.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Sep 2018

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 31, 2017

Completed
1 month until next milestone

First Posted

Study publicly available on registry

December 14, 2017

Completed
9 months until next milestone

Study Start

First participant enrolled

September 1, 2018

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 20, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 20, 2019

Completed
1.7 years until next milestone

Results Posted

Study results publicly available

November 20, 2020

Completed
Last Updated

November 20, 2020

Status Verified

October 1, 2020

Enrollment Period

7 months

First QC Date

October 31, 2017

Results QC Date

April 20, 2020

Last Update Submit

October 28, 2020

Conditions

Outcome Measures

Primary Outcomes (3)

  • Postprandial, Resting Muscle Protein Synthesis Rates

    Assessed using stable isotope infusions of phenylalanine.

    3 hour measure of muscle protein synthesis

  • Postprandial, Post-exercise Muscle Protein Synthesis Rates

    Assess using stable isotope infusions of phenylalanine.

    3 hour measure of muscle protein synthesis

  • How Well Participants Suppress the Degradation of Body Proteins While Stimulating the Growth of New Proteins After Ingesting Varying Doses of EAA at Rest and After Exercise. Net Whole-body Protein Balance

    Assessed using stable isotope infusions of tyrosine. Net Whole-body Protein Balance is defined as whole-body protein synthesis - whole-body protein breakdown)

    3 hour measure of whole-body protein balance

Study Arms (2)

Standard EAA Dose

EXPERIMENTAL

EAA dose provided at 0.10 g/kg body mass

Dietary Supplement: Standard EAA

High EAA Dose

EXPERIMENTAL

EAA dose provided at 0.30 g/kg body mass

Dietary Supplement: High EAA

Interventions

Standard EAADIETARY_SUPPLEMENT

EAA provided relative to body mass at a standard dose (0.10 g/kg) during energy deprivation

Standard EAA Dose
High EAADIETARY_SUPPLEMENT

EAA provided relative to body mass at a high dose (0.30 g/kg) during energy deprivation

High EAA Dose

Eligibility Criteria

Age18 Years - 35 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Men and women aged 18 - 35 years
  • Body mass index \< 30.0 kg/m2
  • Healthy without evidence of chronic illness or musculoskeletal injury as determined by the USARIEM Office of Medical Support and Oversight (OMSO)
  • Resistance exercise trained defined by self-report as performing ≥ 2 sessions/wk for previous 6 mo
  • Refrain from taking any nonsteroidal anti-inflammatory drugs (e.g., aspirin, Advil®, Aleve®, Naprosyn®), or any other aspirin-containing product for 10 days before starting and at least 5 days after completing the study
  • Willing to refrain from alcohol, smoking any nicotine product (includes e-cigarettes); vaping, chewing tobacco, caffeine, and dietary supplement use throughout the entire study period
  • Supervisor approval for federal civilian employees and non-HRV active duty military personnel working within the US Army Natick Soldier Systems Center

You may not qualify if:

  • Musculoskeletal injuries that compromise exercise capability as determined by the USARIEM Office of Medical Support and Oversight (OMSO)
  • Metabolic or cardiovascular abnormalities, gastrointestinal disorders (e.g., kidney disease, diabetes, cardiovascular disease, etc.)
  • Abnormal PT/PTT test or problems with blood clotting
  • History of complications with lidocaine
  • Present condition of alcoholism, anabolic steroids, or other substance abuse issues
  • Blood donation within 8-wk of beginning the study
  • Pregnancy (self-report or results of urine pregnancy test before body composition testing)
  • Unwillingness or inability to consume study diets or foods provided

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

US Army Research Institute of Environmental Medicine

Natick, Massachusetts, 01760, United States

Location

Related Publications (1)

  • Gwin JA, Church DD, Hatch-McChesney A, Howard EE, Carrigan CT, Murphy NE, Wilson MA, Margolis LM, Carbone JW, Wolfe RR, Ferrando AA, Pasiakos SM. Effects of high versus standard essential amino acid intakes on whole-body protein turnover and mixed muscle protein synthesis during energy deficit: A randomized, crossover study. Clin Nutr. 2021 Mar;40(3):767-777. doi: 10.1016/j.clnu.2020.07.019. Epub 2020 Jul 22.

Results Point of Contact

Title
Jess Gwin
Organization
US Army Research Institute of Environmental Medicine

Study Officials

  • Stefan M Pasiakos, PhD

    Military Nutrition Division, USARIEM

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
BASIC SCIENCE
Intervention Model
CROSSOVER
Model Details: Randomized, double-blind, cross-over controlled trial
Sponsor Type
FED
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 31, 2017

First Posted

December 14, 2017

Study Start

September 1, 2018

Primary Completion

March 20, 2019

Study Completion

March 20, 2019

Last Updated

November 20, 2020

Results First Posted

November 20, 2020

Record last verified: 2020-10

Data Sharing

IPD Sharing
Will not share

Locations